Target intelligence / Profile preview

Class C beta-lactamase enzyme

Molecular classification
Enzyme, Hydrolase, Serine hydrolase (Class C), Beta-lactamase family (PF00144)
01

Overview

Class C beta-lactamases are enzymes produced by many Gram-negative bacteria that confer resistance to a broad range of beta-lactam antibiotics, especially cephalosporins. These enzymes hydrolyze the characteristic four-membered β‑lactam ring found in these drugs through a serine-dependent mechanism at their active site. The structure typically features two domains with conserved motifs critical for catalysis—most notably involving residues such as Ser64, Lys67, Tyr150 according to standard numbering schemes—and an omega loop important for substrate binding and specificity. Genes encoding these enzymes can be located on chromosomes or mobile genetic elements like plasmids, facilitating their spread among bacterial populations. Over 8,000 variants have been described with significant sequence diversity but conserved catalytic function. Their activity is a major driver of antimicrobial resistance globally and presents significant challenges for infection treatment due to limited efficacy of many traditional inhibitors against this enzyme class[1][2][3][4].

Other names
Class C β-lactamaseCephalosporinaseAmpC beta-lactamase (for some family members)Serine beta-lactamase (Class C type)
02

Mechanism of action

Hydrolyzes the four-membered β-lactam ring of antibiotics via a serine-based nucleophilic attack at the active site; this deactivates the antibiotic and confers resistance to bacteria producing these enzymes[1][2][3].

03

Biological functions

Hydrolysis of beta-lactam antibioticsAntibiotic resistance mechanism in bacteria
04

Disease associations

Infection (specifically, bacterial infections resistant to beta-lactams)Other (antimicrobial resistance)
05

Safety considerations

Rapid emergence and spread among Gram-negative pathogens due to chromosomal and mobile genetic elements carrying class C genes[3].
06

Interacting drugs

Beta-lactam antibiotics, including penicillins, cephalosporins, cephamycins, monobactams[2][4]

5 more in the full profile.

07

Biomarkers

Presence or overexpression of ampC gene or related class C β-lactamases in clinical isolates as a marker for resistance to certain β-lactams[4].

Beyond the preview

Go deeper on Class C beta-lactamase enzyme.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Class C beta-lactamase enzyme.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call